文献速递临床试验与 GCP新药、器械与细胞基因治疗研发

预防性切口负压伤口治疗预防腹股沟淋巴结清扫术后血清肿(SEROMA试验):随机对照试验研究方案

Prevention of seroma following inguinal lymph node dissection with prophylactic, incisional, negative-pressure wound therapy (SEROMA trial): study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2018-08-15

SEROMA试验是一项随机对照研究方案,旨在评估腹股沟淋巴结清扫术后立即预防性应用切口负压伤口治疗(iNPWT)能否减少需要治疗的血清肿患者数,并与标准术后治疗比较。次要结局包括手术部位感染、裂开、血肿、住院时长、生活质量、安全性、长期淋巴水肿评估及肿瘤学非劣效性。该试验为首个评估iNPWT预防黑色素瘤相关ILND术后并发症的随机研究。

要点

  • 预防性iNPWT可能减少ILND术后血清肿及相关并发症。
  • 次要结局涵盖感染、裂开、血肿、住院时长、生活质量及长期淋巴水肿。
  • 随访在术后7天、14天、1个月、3个月和2年进行。

核心结论

  • 该研究方案旨在评估预防性iNPWT能否减少ILND术后需要治疗的血清肿患者数,并改善短期和长期并发症。

研究设计与样本

  • 随机对照试验,比较ILND术后立即预防性应用iNPWT与标准术后治疗。
  • 主要目的是研究iNPWT是否减少需要治疗血清肿的患者数。
  • 数据在术后7天、14天、1个月、3个月和2年通过病例报告表和问卷前瞻性登记。

关键数值与推荐

  • 主要结局为需要治疗血清肿的患者数。
  • 次要结局包括手术部位感染、裂开、血肿、住院时长、生活质量、安全性、长期淋巴水肿评估及肿瘤学非劣效性。

临床怎么用

  • 若证实有效,预防性iNPWT可能为ILND术后提供改进的术后管理方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Radical inguinal lymphadenectomy (ILND) for metastatic melanoma is associated with a high complication rate. Seroma is often the first postoperative complication, followed by prolonged wound healing sometimes requiring reoperation, infection, multiple outpatient visits and re-hospitalization. Prevention of seroma may, therefore, lead to a reduction in many of the other complications. METHODS/DESIGN: The primary aim of this randomized study is to investigate whether fewer patients require treatment for seroma by immediate prophylactic application of incisional, Negative-pressure Wound Therapy (iNPWT) following ILND, compared to standard postoperative treatment. The secondary outcomes include surgical-site infection, dehiscence, hematoma, length of hospitalization, quality of life, safety, long-term assessment of lymphedema and non-inferiority oncological outcome. Data will be registered prospectively at check-ups after 7 and 14 days, 1 and 3 months and 2 years after inguinal lymphadenectomy using case report forms and questionnaires and stored in a secure online database. DISCUSSION: To our knowledge, this trial is the first randomized study evaluating negative-pressure wound therapy as a prophylactic intervention for complications following melanoma-related ILND. The results from this trial will hopefully determine the efficacy and safety of prophylactic iNPWT treatment in prevention of the clinical relevant short- and long-term postoperative complications following ILND and may provide an evidence base for the an improved postoperative regimen. TRIAL REGISTRATION: ClinicalTrials.gov, ID: NCT03433937 . Prospectively registered on 15 February 2018.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Jørgensen MG, Toyserkani NM, Hyldig N, et al. Prevention of seroma following inguinal lymph node dissection with prophylactic, incisional, negative-pressure wound therapy (SEROMA trial): study protocol for a randomized controlled trial. Trials. 2018. PMID: 30111378. doi:10.1186/s13063-018-2757-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。